Beta-receptor blockers in primary prevention for cardiovascular disease: forgotten benefits?

被引:0
作者
P M Nilsson
G Berglund
机构
[1] University Hospital,Department of Clinical Sciences Medicine
来源
Journal of Human Hypertension | 2006年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:719 / 721
页数:2
相关论文
共 102 条
[1]  
Prichard BNC(1969)Treatment of hypertension with propranolol BMJ 1 7-16
[2]  
Gillam PMS(1996)Antihypertensive treatment in the elderly Clin Exp Hypertens 18 435-447
[3]  
Lindholm LH(2000)Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 1295-1302
[4]  
Hjalmarson A(2000)Effect of Eur J Heart Failure 2 407-412
[5]  
Goldstein S(2003)1 blockade with atenolol on progression of heart failure in patients treated with high dose enalapril J Cardiac Fail 9 354-363
[6]  
Fagerberg B(1972)BEST Investigators. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS Neurology 22 366-368
[7]  
Wedel H(1976)The treatment of migraine with propranolol Headache 16 238-245
[8]  
Waagstein F(1990)Propranolol for migraine prophylaxis Drugs 39 355-373
[9]  
Kjekshus J(1979)Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine Eur J Clin Pharmacol 15 215-217
[10]  
Sturm B(1966)Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin Am J Cardiol 18 431-436